•  
  •  
  •  
  •  

2025-12-25 05:20:41

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Deepak Mining Solutions Ltd to acquire 100% in Explosives Manufacturer
  • BharatRohan Airborne Innovations secures DGCA Type Certification for 'Pravir-X6', Advancing Sustainable Farm Mechanization
  • Karnataka HC sets aside IT assessment order with demand of Rs. 779.56 Mn against Aequs Limited
  • Silicon Rental Solutions Ltd receives order from Techfruits Solutions Pvt Ltd
  • Royal Orchid Hotels Strengthens Central India Portfolio with New Signing in Gwalior, Madhya Pradesh

Keywords Selected:  Inspection

Stock Report

  • Strides Pharma Inc's Chestnut Ridge facility gets 4 observations from USFDA
  • US FDA determines Sun Pharma's Baska facility inspection classification as OAI
  • Successful completion of USFDA inspection at Vizag facility
  • Apitoria Pharma Pvt Ltd receives 3 observations from USFDA for Unit-V
  • GMP Inspection by Malta Medicines Authority at Alkem's manufacturing facility located at Daman, India
  • Ipca Laboratories Ltd receives 3 observations from USFDA for API facility at Tarapur
  • Granules India's Packaging Facility in US Completes FDA inspection with Zero Observations
  • Glenmark Pharmaceuticals Ltd update on USFDA PAI at Chhatrapati Sambhajinagar Facility
  • Innoxel Lifesciences Successfully Completes EU GMP Inspection by Belgium's FAMHP
  • GMP Inspection by Ministry of Health, Armenia at Alkem's manufacturing facility located at Sikkim, India
  • Shilpa Medicare Ltd receives 8 observations from USFDA for Unit 4 at Jadcherla
  • Lupin Ltd receives 7 observations from USFDA for Goa manufacturing facility
  • NATCO Pharma Ltd receives 7 Observations from USFDA for API unit at Manali, Chennai
  • Solara announces successful closure of US FDA inspection of its Mangalore Facility with continued state of compliance on cGMP
  • Aurobindo Pharma gets 9 observations from USFDA for Unit 2 of Eugia Pharma Specialities Ltd
  • USFDA inspects Unit 1 of Divi's Laboratories Limited
  • Closure of USFDA inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Lupin Bioresearch Center receives Zero Observations from U.S. FDA after Successful Inspection and Assessment
  • Innova Captab Limited updates on SMDC inspection
  • Biocon Limited updates on GMP inspection by USFDA at its Cranbury, New Jersey facility
  • Lupin gets one observation from USFDA for Somerset, New Jersey manufacturing facility
  • Emcure Pharmaceuticals Ltd completes surveillance inspection by USFDA without any observation
  • Zydus receives EIR for the oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Jubilant Pharmova announces Completion of Pharmacovigilance Inspection by the USFDA with No Observations

Latest Post

  • Deepak Mining Solutions Ltd to acquire 100% in Explosives Manufacturer
  • BharatRohan Airborne Innovations secures DGCA Type Certification for 'Pravir-X6', Advancing Sustainable Farm Mechanization
  • Karnataka HC sets aside IT assessment order with demand of Rs. 779.56 Mn against Aequs Limited
  • Silicon Rental Solutions Ltd receives order from Techfruits Solutions Pvt Ltd
  • Royal Orchid Hotels Strengthens Central India Portfolio with New Signing in Gwalior, Madhya Pradesh


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024